trial · primary record
INCA033989
Healthy Participants
| Phase | Phase 1 |
|---|---|
| Status | ACTIVE |
| Sponsor | Unknown |
| Enrolment | 108 |
| Primary completion | 2026-11-14 |
| Primary endpoint | Pharmacokinetics Parameter: Cmax of INCA33989 following a single SC administration compared with a single IV infusion |
| Registry ID | NCT07448155 |
Provenance
- Source: ClinicalTrials.gov
- Fetched at: 2026-10-29T14:31:55.156Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: NCT07448155
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.